Literature DB >> 10903394

Looking back at Cannabis research.

R Mechoulam1.   

Abstract

Research leading to the isolation of the plant cannabinoids during the 1960 s and to the endogenous cannabinoids, during the 1990 s is described. Investigations on two non-psychotropic, synthetic cannabinoids, HU-211, a neuroprotective agent and HU-308, a specific CB2 agonist are presented.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10903394     DOI： 10.2174/1381612003399509

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN： 1381-6128            Impact factor:   3.116


  6 in total

1.  Crystallization of Delta1-tetrahydrocannabinolic acid (THCA) synthase from Cannabis sativa.

Authors:  Yoshinari Shoyama; Ayako Takeuchi; Futoshi Taura; Taro Tamada; Motoyasu Adachi; Ryota Kuroki; Yukihiro Shoyama; Satoshi Morimoto
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-07-30

2.  Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine.

Authors:  Allan J Barnes; Sheena Young; Eliani Spinelli; Thomas M Martin; Kevin L Klette; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2014-04-24       Impact factor: 2.395

Review 3.  Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

Authors:  William E Greineisen; Helen Turner
Journal:  Int Immunopharmacol       Date:  2010-02-25       Impact factor: 4.932

4.  Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

Authors:  Luciano De Petrocellis; Alessia Ligresti; Aniello Schiano Moriello; Marco Allarà; Tiziana Bisogno; Stefania Petrosino; Colin G Stott; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.

Authors:  J Manzanares; Md Julian; A Carrascosa
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

Review 6.  Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System.

Authors:  Julius Gene S Latorre; Elena B Schmidt
Journal:  Curr Cardiol Rep       Date:  2015-09       Impact factor: 2.931
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.